Use of the Desmopressin Test in the Differential Diagnosis of Pseudo-Cushing State from Cushing’s Disease
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
CONTEXT: The desmopressin (DDAVP) test has been proposed to discriminate Cushing's disease (CD) from pseudo-Cushing states (PC); however, current information on its value is scarce and contradictory. OBJECTIVE: The aim of the study was to assess the ability of the DDAVP test in distinguishing between these conditions, with emphasis on subjects with mild hypercortisolism. DESIGN AND SETTING: We conducted a retrospective/prospective study at the Division of Endocrinology, Polytechnic University of Marche, Ancona, Italy. PATIENTS: The study included 52 subjects with CD, 28 with PC, and 31 control subjects (CT). INTERVENTION(S): We performed the DDAVP test and standard diagnostic procedures for the diagnosis of Cushing's syndrome. MAIN OUTCOME MEASURE(S): The diagnosis/exclusion of CD was measured. RESULTS: Interpretation of the DDAVP test based on percentage and absolute increment of cortisol and ACTH did not afford acceptable values of both sensitivity (SE) and specificity (SP). CD diagnosis based on simultaneous positivity for basal serum cortisol greater than 331 nmol/liter and absolute ACTH increment greater than 4 pmol/liter and its exclusion in subjects negative for one or both measures yielded an SE of 90.3% and an SP of 91.5%. The approach was also highly effective in distinguishing PC from: 1) CD with moderate values of urinary free cortisol (SE, 86.9%; SP, 92.8%); 2) CD with moderate values of serum cortisol after dexamethasone suppression (SE, 86.6%; SP, 92.8%); and 3) CD with moderate values of midnight serum cortisol (SE, 100%; SP, 92.8%). CONCLUSIONS: Interpretation of the DDAVP test through a combination of parameters allowed effective discrimination of CD from PC, even in subjects with mild hypercortisolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00108-7 · Cited by 3,638
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s43 · Cited by 924
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome
Findling, J. W., Raff, H., & Aron, D. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030207 · Cited by 165
Diagnosis and differential diagnosis of Cushing’s syndrome
Findling, J. W., & Raff, H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70209-7 · Cited by 147
Pecori Giraldi, F., Pivonello, R., Ambrogio, A. G., De Martino, M. C., De Martin, M., Scacchi, M., Colao, A., Toja, P. M., Lombardi, G., & Cavagnini, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02717.x · Cited by 141
Friedman, T. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924281 · Cited by 19
Research works printed but not linked: 30
- Boscaro, 2009, Approach to the patient with possible Cushing’s syndrome, J Clin Endocrinol Metab, 94, 3121, 10.1210/jc.2009-0612 · DOI · Paper page
- Moro, 2000, The desmopressin test in the differential diagnosis between Cushing’s disease and pseudo-Cushing states, J Clin Endocrinol Metab, 85, 3569
- Malerbi, 1996, Cortisol and adrenocorticotropin response to desmopressin in women with Cushing’s disease compared with depressive illness, J Clin Endocrinol Metab, 81, 2233
- Arnaldi, 1998, Vasopressin receptors modulate the pharmacological phenotypes of Cushing’s syndrome, Endocr Res, 24, 807, 10.3109/07435809809032691 · DOI
- de Keyzer, 1998, Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours, Clin Endocrinol (Oxf), 49, 475, 10.1046/j.1365-2265.1998.00560.x · DOI · Paper page
- Gatta, 2007, Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing’s disease from pseudo-Cushing’s syndrome, J Clin Endocrinol Metab, 92, 4290, 10.1210/jc.2006-2829 · DOI · Paper page
- Erickson, 2007, Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism, J Clin Endocrinol Metab, 92, 2972, 10.1210/jc.2006-2662 · DOI · Paper page
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098 · DOI · Paper page
- Papanicolaou, 1998, A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states, J Clin Endocrinol Metab, 83, 1163
- Holm, 1979, A simple sequentially rejective multiple test procedure, Scand J Statist, 6, 65
- Barry, 1997, Test characteristics and decision rules, Endocrinol Metab Clin North Am, 26, 45, 10.1016/S0889-8529(05)70233-4 · DOI
- Glantz, 2005, Primer of biostatistics, 6th ed. New York: McGraw-Hill Professional;, 242
- Shultz, 1995, Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example, Clin Chem, 41, 1248, 10.1093/clinchem/41.8.1248 · DOI
- Hosmer, 2000, Applied logistic regression, 2nd ed. New York: John Wiley and Sons;, 160
- DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 · DOI · Paper page
- Carpenter, 1988, Diagnostic evaluation of Cushing’s syndrome, Endocrinol Metab Clin North Am, 17, 445, 10.1016/S0889-8529(18)30412-2 · DOI
- Harris, 2002, Endocrinology in clinical practice, 10.1201/b15291 · DOI
- Erkut, 1998, Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons, J Clin Endocrinol Metab, 83, 2066
- Itoi, 1987, Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus, Neurosci Lett, 73, 231, 10.1016/0304-3940(87)90250-3 · DOI
- McFarlane, 1995, Cortisol feedback in adrenalectomized adult sheep, Am J Physiol, 269, E10
- Shipston, 1991, Early glucocorticoid feedback in anterior pituitary corticotrophs: differential inhibition of hormone release induced by vasopressin and corticotrophin-releasing factor in vitro, J Endocrinol, 129, 261, 10.1677/joe.0.1290261 · DOI
- Nicholson, 1989, Glucocorticoids act rapidly in vitro to attenuate second messenger responses to ACTH secretagogues in rats, J Endocrinol, 122, 545, 10.1677/joe.0.1220545 · DOI
- Schwartz, 1994, Secretion of adrenocorticotrophin (ACTH) and ACTH precursors in ovine anterior pituitary cells: actions of corticotrophin-releasing hormone, arginine vasopressin and glucocorticoids, J Endocrinol, 140, 189, 10.1677/joe.0.1400189 · DOI
- Durand, 1986, In vitro stimulation and inhibition of adrenocorticotropin release by pituitary cells from ovine fetuses and lambs, Endocrinology, 118, 1387, 10.1210/endo-118-4-1387 · DOI
- Juruena, 2004, The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression, Rev Bras Psiquiatr, 26, 189, 10.1590/S1516-44462004000300009 · DOI · Paper page
- Young, 2006, Disordered adrenocorticotropin secretion in women with major depression, J Clin Endocrinol Metab, 91, 1924, 10.1210/jc.2005-2397 · DOI · Paper page
- Pecori Giraldi, 2003, Corticotrophin-releasing activity of desmopressin in Cushing’s disease: lack of correlation between in vivo and in vitro responsiveness, J Endocrinol, 177, 373, 10.1677/joe.0.1770373 · DOI
- Zakowski, 2004, Evidence-based medicine: answering questions of diagnosis, Clin Med Res, 2, 63, 10.3121/cmr.2.1.63 · DOI
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Measuring cortisol in serum, urine and saliva—Are our assays good enough?
El-Farhan, N., Rees, D. A., & Evans, C. (2017) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216687335 · Cited by 395
Cushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210
“71,72 If the diagnosis remains unclear, dexamethasone-suppressed CRH stimulation (Dex-CRH) test 73,74 or the desmopressin test 75,76 can be performed to distinguish further between CD and pseudo-Cushing’s states.”
Raff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141
“Although this test is usually not required, it may help to resolve the diagnosis in patients without definitive screening test results (256).”
Findling, J. W., & Raff, H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0946 · Cited by 134
Metadata
- Authors
- Tirabassi, G., Faloia, E., Papa, R., Furlani, G., Boscaro, M., & Arnaldi, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 1115-1122
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2155233720
- Cited by
- 90
- References
- 10
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of the Desmopressin Test in the Differential Diagnosis of Pseudo-Cushing State from Cushing’s Disease. https://app.cochat.ai/papers/10.1210/jc.2009-1146
- The paper
- Tirabassi, G., Faloia, E., Papa, R., Furlani, G., Boscaro, M., & Arnaldi, G. (2010). Use of the Desmopressin Test in the Differential Diagnosis of Pseudo-Cushing State from Cushing’s Disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2009-1146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.